AgBR1与NeSt1抗血清联合保护小鼠抵御埃及伊蚊传播的寨卡病毒感染
该研究在小鼠模型中评估被动免疫针对埃及伊蚊唾液蛋白AgBR1和NeSt1的抗血清对蚊媒寨卡病毒感染的保护作用。先前研究表明单一抗血清可部分保护并降低病毒血症,本研究显示联合使用两种抗体可增强生存率并减少血液病毒载量,提示靶向蚊唾液蛋白组合可能作为预防蚊媒寨卡感染的疫苗策略。
要点
- 联合AgBR1和NeSt1抗血清被动免疫可提高小鼠生存率并降低血液病毒载量。
- 单一抗血清先前显示部分保护并减少病毒血症,联合方案效果增强。
- 靶向蚊唾液蛋白组合是潜在的预防蚊媒寨卡感染的疫苗策略。
核心结论
- 联合被动免疫AgBR1和NeSt1特异性抗体可增强小鼠对蚊媒寨卡病毒感染的保护,表现为生存率提高和血液病毒载量降低。
研究设计与样本
- 小鼠模型研究,评估被动免疫联合AgBR1和NeSt1抗血清对埃及伊蚊传播的寨卡病毒感染的保护效果。
主要发现
- 联合被动免疫AgBR1和NeSt1特异性抗体增强了小鼠生存率并降低了血液中的病毒载量。
- 先前研究表明单一AgBR1或NeSt1抗血清被动免疫可部分保护小鼠并降低病毒血症。
临床怎么用
- 提示靶向蚊唾液蛋白组合可能作为预防蚊媒寨卡病毒感染的疫苗策略,但尚未应用于人类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Zika virus(ZIKV) is primarily spread by Aedes. aegyptimosquitoes. Infection with ZIKV can result in diverse clinical symptoms in humans, ranging from mild to severe. Previously, we demonstrated that passive immunization against A. aegypti AgBR1 or NeSt1 antiserum, two mosquito saliva proteins that are transmitted with the virus, conferred partial protection against ZIKV in mice. Each individual antiserum altered the early host response in the skin and reduced viremia. Here, we show that passive immunization with a combination of AgBR1- and NeSt1-specific antibodies enhanced survival and reduced the viral burden in blood, thereby protecting mice from mosquito-borne ZIKV infection. This finding suggests that targeting a combination of mosquito saliva proteins, with AgBR1 and NeSt1 as model antigens, may be used as a vaccine strategy to help prevent mosquito-borne ZIKV infection.
引用
- Marin-Lopez A, Wang Y, Jiang J, et al. AgBR1 and NeSt1 antisera protect mice from Aedes aegypti-borne Zika infection. Vaccine. 2021. PMID: 33622591. doi:10.1016/j.vaccine.2021.01.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。